CompoAtlas

GI Calm (Capsule)

Natural health product licensed in Canada

Other names
Alimentin, GI Calm, Pro Gi Calm
Licence holder
Advanced Orthomolecular Research Inc.
NPN or DIN-HM
80102492
Status
Active licence
Licence date
7 July 2020
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Vitamine D

Source : Cladina rangiferina - En entier

6.25 mcg25 µg
Protéase

Source : Aspergillus niger - En entier

13.75 FCC SAPUNot calculated
Protéase

Source : Aspergillus flavus var. oryzae - En entier

13.75 FCC SAPUNot calculated
Withania somnifera

Source : Feuille

Extract : Matériel brut sec

Extraction ratio : 40:1

Dry plant equivalent : 1,200 mg

Potency : 35 % Withanolide glycosides

30 mgNot calculated
Withania somnifera

Source : Racine

Extract : Matériel brut sec

Extraction ratio : 40:1

Dry plant equivalent : 1,200 mg

Potency : 35 % Withanolide glycosides

30 mgNot calculated
Boswellia serrata

Source : Gum oleoresin

Extract : Matériel brut sec

Extraction ratio : 5:1

Dry plant equivalent : 750 mg

Potency : 44 % Boswellic acids

150 mgNot calculated
Saccharomyces cerevisiae

Source : 0-B03-I

3.33 Milliards d'UFCNot calculated
Saccharomyces cerevisiae

Source : En entier

3.33 Milliards d'UFCNot calculated
Zingiber officinale

Source : Rhizome

Extract : Matériel brut sec

Extraction ratio : 10:1

Dry plant equivalent : 750 mg

75 mgNot calculated
Protéase

Source : Aspergillus niger - En entier

3.4 mgNot calculated
Protéase

Source : Aspergillus flavus var. oryzae - En entier

3.4 mgNot calculated

Non-medicinal ingredients

Sucrose, Hydroxypropylcellulose, Hypromellose, Fécule de pomme de terre, Poudre de racine de carotte, Stéaryl fumarate de sodium, Palmitate d'ascorbyle, NA, d-alpha tocophérol, Cellulose microcristalline, Maltodextrine, Bêta-cyclodextrine, Dextrine, Gomme arabique (acacia), Amidon de maïs modifié, Dioxyde de silicium, Phosphate de tricalcium

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years2 Capsule2 Tous les jours
Adultesminimum: 19 years4 Capsule1 Tous les jours

Uses authorised in Canada

Ginger is traditionally used in herbal medicine to help relieve digestive upset / disturbances including lack of appetite. Nausea, digestive spasms. Indigestion, dyspepsia and flatulent colic (carminative). This product contains a probiotic that forms part of a natural healthy gut flora to confer a health benefit and helps reduce the risk of antibiotic-associated diarrhea. It also contains fungal proteases that function as digestive aids that help digest proteins. It is a factor in the maintenance of good health, helps in the development and maintenance of bones and teeth, and in the absorption and use of Calcium and Phosphorus. It helps in the absorption and use of calcium and phosphorous; and helps to build strong bones and teeth. It helps to support immune function and prevent vitamin D deficiency. Calcium intake, when combined with sufficient Vitamin D, a healthy diet and regular exercise may reduce the risk for developing osteoporosis.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80102492

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line